Kuriakose Emil 4
4 · Terns Pharmaceuticals, Inc. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
Kuriakose Emil
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+120,000→ 120,000 totalExercise: $6.59Exp: 2034-12-11→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from December 12, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.